Peptides & Kidney Disease: What Research Says

Peptide claims are everywhere—but reliable information about their use in kidney disease is much harder to find.

This free Dialysis Decoded guide explains what the research actually shows, what remains theoretical or experimental, and where evidence in advanced kidney disease and dialysis is still missing.

This guide is for you if you want to:

• Understand the difference between approved medications, investigational compounds, and online “research peptides”

• Learn what has actually been studied in humans versus cells or animals

• Explore the current evidence for ARA-290, SS-31/elamipretide, BPC-157, KPV, and NAD+

• Understand the FLOW trial and why GLP-1 medications are now part of the kidney-protection conversation

• Know which findings apply specifically to adults with type 2 diabetes and chronic kidney disease

• Ask better-informed questions at your next nephrology appointment

You’ll also receive a clickable research library linking directly to primary studies, FDA materials, clinical trials, and kidney guidelines.

Created by Aubrey Westlake, BSN, RN—a dialysis nurse and the creator of Dialysis Decoded.

This guide is for general education only. It is not medical advice or a recommendation to purchase, obtain, inject, dose, or use peptides or research compounds. Always discuss medications, supplements, and compounded or investigational products with your nephrologist or healthcare team.